DALLAS, July 20, 2020 /PRNewswire/ — Puration, Inc. (USOTC: PURA) today confirmed that the terms of the acquisition of PURA’s cannabis cultivation spinoff by PAO Group, Inc. (USOTC: PAOG) include a dividend distribution of PAOG stock to PURA shareholders. The target dividend ratio is for each PURA shareholder to receive one share of PAOG stock for each share of PURA held. The PURA and PAOG transaction is anticipated to be executed by the end of July.
PAOG also intends to acquire NCM Biotech from Kali-Extracts, Inc. (KALY). NCM Biotech is focused on medical research and the development of treatments derived from its patented cannabis extraction process.
For more information on Puration, visit http://www.purationinc.com
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
+1 (800) 861-1350
SOURCE Puration, Inc.